blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2313013

EP2313013 - EMBOLIC COIL IMPLANT SYSTEM [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  27.01.2017
Database last updated on 27.07.2024
Most recent event   Tooltip20.07.2018Lapse of the patent in a contracting state
New state(s): MT		published on 22.08.2018  [2018/34]
Applicant(s)For all designated states
Penumbra, Inc.
1351 Harbor Bay Parkway
Alameda, CA 94502 / US
[2011/17]
Inventor(s)01 / TOMPKINS, Ben
1609 N. Clear Creek Place
Danville CA 94526 / US
02 / BOSE, Arani
322 East 18th Street
New York NY 10003 / US
03 / HUI, Delilah
119 Via Bellagio
American Canyon CA 94503 / US
04 / BARRY, David
10 Terra Way
Livermore CA 94550 / US
05 / PONS, Stephen
3171 Sacramento Street
San Francisco CA 94115 / US
06 / LEYNOV, Aleksander
16 Brandon Oaks Place
Walnut Creek CA 94597 / US
 [2011/17]
Representative(s)Millburn, Julie Elizabeth
Reddie & Grose LLP The White Chapel Building
10 Whitechapel High Street
London E1 8QS / GB
[N/P]
Former [2016/12]Millburn, Julie Elizabeth
Reddie & Grose LLP
16 Theobalds Road
London WC1X 8PL / GB
Former [2011/17]Millburn, Julie Elizabeth
Reddie & Grose 16 Theobalds Road London
WC1X 8PL / GB
Application number, filing date09790305.810.07.2009
[2011/17]
WO2009US50319
Priority number, dateUS2009049875207.07.2009         Original published format: US 498752
US20080083111P23.07.2008         Original published format: US 83111 P
US20080080742P15.07.2008         Original published format: US 80742 P
[2011/17]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2010009019
Date:21.01.2010
Language:EN
[2010/03]
Type: A1 Application with search report 
No.:EP2313013
Date:27.04.2011
Language:EN
The application published by WIPO in one of the EPO official languages on 21.01.2010 takes the place of the publication of the European patent application.
[2011/17]
Type: B1 Patent specification 
No.:EP2313013
Date:23.03.2016
Language:EN
[2016/12]
Search report(s)International search report - published on:EP21.01.2010
ClassificationIPC:A61B17/12
[2011/17]
CPC:
A61B17/12154 (EP,US); A61B17/12022 (EP,US); A61B17/12113 (EP,US);
A61B17/1214 (US); A61B17/12145 (EP,US); A61B17/12181 (EP,US);
A61B2017/00871 (US); A61B2017/12054 (EP,US); A61B2017/1209 (US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2016/12]
Former [2011/17]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  SM,  TR 
TitleGerman:EMBOLIE-SPULEN-IMPLANTATIONSSYSTEM[2011/17]
English:EMBOLIC COIL IMPLANT SYSTEM[2011/17]
French:SYSTÈME D IMPLANT DE TYPE SPIRE D EMBOLISATION[2011/17]
Entry into regional phase10.02.2011National basic fee paid 
10.02.2011Designation fee(s) paid 
10.02.2011Examination fee paid 
Examination procedure10.02.2011Examination requested  [2011/17]
06.04.2011Amendment by applicant (claims and/or description)
16.09.2015Communication of intention to grant the patent
18.01.2016Fee for grant paid
18.01.2016Fee for publishing/printing paid
18.01.2016Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  16.09.2015
Opposition(s)02.01.2017No opposition filed within time limit [2017/09]
Fees paidRenewal fee
23.06.2011Renewal fee patent year 03
25.07.2012Renewal fee patent year 04
10.07.2013Renewal fee patent year 05
14.07.2014Renewal fee patent year 06
27.07.2015Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU10.07.2009
AT23.03.2016
BE23.03.2016
CY23.03.2016
CZ23.03.2016
EE23.03.2016
FI23.03.2016
HR23.03.2016
LT23.03.2016
LV23.03.2016
MC23.03.2016
MK23.03.2016
NL23.03.2016
PL23.03.2016
RO23.03.2016
SE23.03.2016
SI23.03.2016
SK23.03.2016
SM23.03.2016
TR23.03.2016
BG23.06.2016
NO23.06.2016
GR24.06.2016
LU10.07.2016
IS23.07.2016
PT25.07.2016
MT31.07.2016
[2018/32]
Former [2018/29]HU10.07.2009
AT23.03.2016
BE23.03.2016
CY23.03.2016
CZ23.03.2016
EE23.03.2016
FI23.03.2016
HR23.03.2016
LT23.03.2016
LV23.03.2016
MC23.03.2016
MK23.03.2016
NL23.03.2016
PL23.03.2016
RO23.03.2016
SE23.03.2016
SI23.03.2016
SK23.03.2016
SM23.03.2016
TR23.03.2016
BG23.06.2016
NO23.06.2016
GR24.06.2016
LU10.07.2016
IS23.07.2016
PT25.07.2016
Former [2018/28]HU10.07.2009
AT23.03.2016
BE23.03.2016
CY23.03.2016
CZ23.03.2016
EE23.03.2016
FI23.03.2016
HR23.03.2016
LT23.03.2016
LV23.03.2016
MC23.03.2016
MK23.03.2016
NL23.03.2016
PL23.03.2016
RO23.03.2016
SE23.03.2016
SI23.03.2016
SK23.03.2016
SM23.03.2016
BG23.06.2016
NO23.06.2016
GR24.06.2016
LU10.07.2016
IS23.07.2016
PT25.07.2016
Former [2017/37]AT23.03.2016
BE23.03.2016
CZ23.03.2016
EE23.03.2016
FI23.03.2016
LT23.03.2016
LV23.03.2016
MC23.03.2016
NL23.03.2016
PL23.03.2016
RO23.03.2016
SE23.03.2016
SI23.03.2016
SK23.03.2016
SM23.03.2016
BG23.06.2016
NO23.06.2016
GR24.06.2016
LU10.07.2016
IS23.07.2016
PT25.07.2016
Former [2017/20]AT23.03.2016
BE23.03.2016
CZ23.03.2016
EE23.03.2016
FI23.03.2016
LT23.03.2016
LV23.03.2016
MC23.03.2016
NL23.03.2016
PL23.03.2016
RO23.03.2016
SE23.03.2016
SK23.03.2016
SM23.03.2016
BG23.06.2016
NO23.06.2016
GR24.06.2016
IS23.07.2016
PT25.07.2016
Former [2017/03]AT23.03.2016
BE23.03.2016
CZ23.03.2016
EE23.03.2016
FI23.03.2016
LT23.03.2016
LV23.03.2016
NL23.03.2016
PL23.03.2016
RO23.03.2016
SE23.03.2016
SK23.03.2016
SM23.03.2016
NO23.06.2016
GR24.06.2016
IS23.07.2016
PT25.07.2016
Former [2016/51]AT23.03.2016
CZ23.03.2016
EE23.03.2016
FI23.03.2016
LT23.03.2016
LV23.03.2016
NL23.03.2016
PL23.03.2016
RO23.03.2016
SE23.03.2016
SK23.03.2016
SM23.03.2016
NO23.06.2016
GR24.06.2016
IS23.07.2016
PT25.07.2016
Former [2016/50]AT23.03.2016
CZ23.03.2016
EE23.03.2016
FI23.03.2016
LT23.03.2016
LV23.03.2016
NL23.03.2016
PL23.03.2016
RO23.03.2016
SE23.03.2016
SK23.03.2016
SM23.03.2016
NO23.06.2016
GR24.06.2016
IS23.07.2016
Former [2016/49]EE23.03.2016
FI23.03.2016
LT23.03.2016
LV23.03.2016
NL23.03.2016
PL23.03.2016
SE23.03.2016
NO23.06.2016
GR24.06.2016
IS23.07.2016
Former [2016/48]FI23.03.2016
LT23.03.2016
LV23.03.2016
NL23.03.2016
SE23.03.2016
NO23.06.2016
GR24.06.2016
IS23.07.2016
Former [2016/40]FI23.03.2016
LT23.03.2016
LV23.03.2016
NL23.03.2016
SE23.03.2016
NO23.06.2016
GR24.06.2016
Former [2016/39]FI23.03.2016
LT23.03.2016
LV23.03.2016
SE23.03.2016
NO23.06.2016
GR24.06.2016
Former [2016/36]FI23.03.2016
LT23.03.2016
NO23.06.2016
GR24.06.2016
Former [2016/35]FI23.03.2016
NO23.06.2016
GR24.06.2016
Cited inInternational search[X]WO9311719  (TARGET THERAPEUTICS INC [US]) [X] 1,3-7 * page 5, line 3 - page 8, line 26; figure - *;
 [A]WO9311825  (TARGET THERAPEUTICS INC [US]) [A] 1-7 * page 4, line 30 - page 8, line 8; figure - *;
 [IA]EP0832607  (TARGET THERAPEUTICS INC [US]) [I] 14,16,19-24 * column 4, line 18 - column 6, line 13; figure 3 * [A] 36-39;
 [X]US5853418  (KEN CHRISTOPHER G M [US], et al) [X] 1,3-7 * column 4, line 10 - column 6, line 37 * * column 7, line 21 - line 67; figures 4A,4B *;
 [X]WO9902094  (TARGET THERAPEUTICS INC [US], et al) [X] 1,3-7 * page 9, line 20 - page 11, line 26; figure 1B *;
 [A]US2005192621  (WALLACE MICHAEL P [US], et al) [A] 1-7 * paragraphs [0077] , [0078]; figures 5a,5b *;
 [I]EP1728477  (CORDIS NEUROVASCULAR INC [US]) [I] 8-11 * paragraph [0025] - paragraph [0031]; figure - *;
 [X]US2006276832  (BALGOBIN KEITH [US], et al) [X] 14,20 * paragraph [0027] - paragraph [0037]; figure - *;
 [XI]EP1797833  (CORDIS NEUROVASCULAR INC [US]) [X] 1-11,14,20,24 * paragraph [0027] - paragraph [0037]; figure - * [I] 23;
 [I]WO2007070797  (CORDIS DEV CORP [US], et al) [I] 8-11,13-14,23-24 * paragraph [0021] - paragraph [0048]; figure - *;
 [I]EP1813213  (CORDIS DEV CORP [US]) [I] 14,16-17,20,22-24 * paragraph [0014] - paragraph [0041]; figure - *;
 [A]WO2007121405  (MICRO THERAPUTICS INC D B A EV [US], et al) [A] 14,36* paragraph [0074] - paragraph [0105]; figures 1-14 *;
 [I]US2007293928  (TOMLIN DAMIAN [US]) [I] 8,14 * paragraph [0023] - paragraph [0040]; figure - *;
 [I]US2008097462  (MITELBERG VLADIMIR [US], et al) [I] 8-12,14,16-18,20-23 * paragraph [0025] - paragraph [0046]; figure - *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.